How is malignant lymphoma treated, and how is malignant lymphoma treated?

Moderately malignant, sensitive to chemoradiotherapy. About 40% can be **.

The standard first-line regimen is CHOP, 6 to 8 cycles, and if economic conditions allow, the R-CHOP regimen, which is rituximab, a monoclonal antibody specifically targeting CD20, is expensive. A combination of affected field radiation therapy is also required.

Hurry up**, the course of lymphoma develops rapidly.

Go to the hospital to receive regular**, choose CHOP or R-CHOP according to the economic situation, and adjust the medication or regimen according to the chemotherapy situation.

According to this condition, rituximab should be used to smash the pot and sell iron, 8 courses of treatment, plus field radiotherapy, and then return to autologous stem cell transplantation if possible, so that the ** may reach 60-80%.

Malignant lymphoma: is a group of malignant tumors that originate in lymphoid tissue. According to the clinical and pathological examination, the disease is mainly divided into Hodgkin lymphoma (Hodgkin S

Lymphoma, HD) and non-Hodgkin lymphoma (Non-Hodgkins

Lymphoma (NHL), of which non-Hodggin lymphoma is divided into T cells and B cells. The degree of malignancy varies, caused by the malignant proliferation of the lymph histiocyte system, mostly occurs in the lymph nodes, and the clinical manifestations are ** and progressive lymphadenopathy, and can also be accompanied by liver and spleen enlargement, and failure and cachexia can occur in the late stage. The disease is more common in middle-aged and young people, and the ratio of men to women is 3:

1. About 5 to 6 cases have a family history. The survival time of lymphoma after ** is related to the type of disease and clinical stage, and the 5-year survival rate after HD chemoradiotherapy is the annual survival rate; The median survival of low-grade malignant NHL is years, that of moderate malignancy, and that of high-grade malignancy. In the same type, the earlier the disease, the better the prognosis; The prognosis is worse in children and older adults in the same type and stage of illness.

Both chemoradiotherapy are sensitive, and a monoclonal antibody specifically targeting CD20 is moderately malignant and expensive, and R-CHOP can be used. About 40% can be **.

Hurry up**, if financial conditions allow. A combination of affected field radiation therapy is also required.

The first-line standard regimen is CHOP, 6-8 cycles, the course of lymphoma progresses rapidly, and the r is rituximab.

Malignant lymphoma is a general term for a group of malignant tumors originating from the lymphoid hematopoietic system, which is mainly manifested as sycamore lymphadenopathy and involves tissues and organs throughout the body. What about malignant lymphoma? In fact, there are many foods in our daily life that have their own effects, seemingly ordinary foods, when paired with the effect of ** disease, let's take a look at the dietary prescription for malignant lymphoma.

1. Dietary prescription for malignant lymphoma

1. Rabbit meat in a boiled rabbit with summer shellfish.

30 grams of prunella vulgaris, 10 grams of Chuanbei, 250 grams of rabbit meat. Break the shellfish, wrap the prunella grass and shellfish with a cloth, and cut the rabbit meat into thin pieces. Add water to the simmer for about 2 hours, remove the prunella spine pants, Chuanbei, and salt to taste.

This medicinal diet has the effect of clearing away heat and nourishing yin, removing phlegm and dispersing knots, and is suitable for patients with malignant lymphoma with hard sputum in the neck, heat and bitterness.

2. Soft-shelled turtle and shredded pork soup.

About 300 grams of soft-shelled turtle and 200 grams of pork. Wash the turtle and cut it into small pieces. Wash the pork and cut into shreds. Put the two things together in a pot and add an appropriate amount of water, first simmer until everything is cooked and rotten, season with salt, drink soup and eat meat.

This medicinal diet has the effect of nourishing the body and nourishing the yin and cooling the blood, and is suitable for people with advanced malignant lymphoma, dizziness and shortness of breath, and those who do not want to eat and drink.

1.Radiation**.

Some types of lymphoma can be treated with radiation therapy alone in the early stages. Radiation therapy can also be used for consolidation after chemotherapy**. 2.Chemical Drugs**.

Chemotherapy for lymphoma is mostly a combination of chemotherapy regimens, which can combine targeted drugs and biologics. In recent years, chemotherapy regimens for lymphoma have improved considerably, and long-term survival rates have improved significantly for many types of lymphoma. 3.Hematopoietic stem cell transplantation.

Autologous hematopoietic stem cell transplantation may be considered for patients younger than 60 years of age who are able to tolerate high-dose chemotherapy if they are able to tolerate it. Allogeneic hematopoietic stem cell transplantation may also be considered for patients with bone marrow invasion. 4.Surgery**.

Limited to tissue biopsy or management of complications. For patients with hypersplenism and no contraindications, splenectomy can be performed for those with an indication for splenectomy, so as to create favorable conditions for the future.

2. The best method for malignant lymphoma

1.Radiation**.

Some types of lymphoma can be treated with radiation therapy alone in the early stages. Radiation therapy can also be used for consolidation after chemotherapy**.

2.Chemical Drugs**.

Chemotherapy for lymphoma is mostly a combination of chemotherapy regimens, which can combine targeted drugs and biologics. In recent years, chemotherapy regimens for lymphoma have improved considerably, and long-term survival rates have improved significantly for many types of lymphoma.

3.Hematopoietic stem cell transplantation.

Autologous hematopoietic stem cell transplantation may be considered in patients younger than 60 years of age who have poor prognostic factors and are able to tolerate high-dose chemotherapy. Allogeneic hematopoietic stem cell transplantation may also be considered for patients with bone marrow invasion.

4.Surgery**.

Limited to tissue biopsy or management of complications. For patients with hypersplenism and no contraindications, splenectomy can be performed for those with an indication for splenectomy, so as to create favorable conditions for the future.

Lymphoma is a malignant tumor originating from the lymphatic hematopoietic system, which is mainly manifested as ** lymphadenopathy, hepatosplenomegaly, all tissues and organs of the body can be affected, accompanied by fever, night sweats, weight loss, itching and other systemic symptoms.

According to the tumor cells, they are divided into two categories: non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). The pathological features of Hodgkin lymphoma are lymphocytes, eosinophils, plasma cells and specific Reed-Steinberg cells in the tumor tissue, and HL is divided into nodular lymphocyte-rich type and classical type according to the pathological type, the latter includes lymphocyte-predominant, nodular sclerosis, mixed cell type and lymphocytodepleting type. The incidence of NHL is much higher than that of HL, and it is the sum of a group of independent diseases with strong heterogeneity, which are mainly lymphocytes, histiocytes or reticular cells with different degrees of differentiation, and can be classified into three major clinical types according to the natural history of NHL, namely highly aggressive, aggressive and indolent lymphoma.

According to the origin of different lymphocytes, it can be divided into B-cell, T-cell, and NK-cell lymphoma.

Lymphoma is highly heterogeneous, so it is also very different, and there are great differences in the intensity and prognosis of lymphoma of different pathological types and stages. The most advanced methods of lymphoma are mainly composed of the following, but specific patients should also be analyzed according to the actual situation of the patient.

1.Radiation**.

Some types of lymphoma can be treated with radiation therapy alone in the early stages. Radiotherapy can also be used for consolidation after chemotherapy and adjuvant for transplantation.

2.Chemical Drugs**.

Lymphoma chemotherapy is mostly a combination of chemotherapy, which can be combined with targeted drugs and biologics. In recent years, chemotherapy regimens for lymphoma have been greatly improved, and the long-term survival of many types of lymphoma has been greatly improved.

3.Bone marrow transplant.

Autologous hematopoietic stem cell transplantation may be considered for patients under 60 years of age who can tolerate high-dose chemotherapy and are at intermediate and high risk. Allogeneic hematopoietic stem cell transplantation may also be considered in young patients with partial** or bone marrow invasion.

4.Surgery**.

Limited to biopsies or complication management; There are no contraindications for hypersplenism, and spleen resection can be performed in patients with indications for splenectomy to improve blood and create favorable conditions for future chemotherapy.

There is no definite answer to whether it can be cured, which can only be decided according to various factors such as the specific degree of the patient's condition, physical and mental quality, and ** situation.

With the continuous improvement of medical standards, patients with early malignant lymphoma can be cured through surgery as long as they are detected and diagnosed early, and they can be consolidated and cured after surgery.

In the past, malignant lymphoma was considered to be an unavoidable disease, but with the development of medicine, I believe that experts have a new understanding of malignant lymphoma. So, can malignant lymphoma be **? Let's find out.

Malignant lymphoma is a kind of systemic disease, is a group of malignant tumors originating from lymph nodes or other lymphoid tissues, can be divided into Hodgkin's disease (referred to as HD) and non-Hodgkin lymphoma (referred to as NHL) two categories, histological lymphocyte and/or histiocyte neoplastic proliferation, clinical lymphadenopathy is the most typical, liver and spleen are often enlarged, cachexia, fever and anemia in the late stage. For malignant lymphoma, comprehensive measures are mostly used at present, that is, according to different tumors, different pathological types and subtypes, different biological behaviors, different disease stages and development trends, different body behavior states and important organ functions, the existing various methods are planned and reasonably applied, in order to maximize the protection of the body, maximize the killing of tumor cells, and achieve the purpose of increasing the rate and improving the quality of life. With the emergence of cellular immunity, malignant lymphoma is incurable, can malignant lymphoma be incurable?

As long as the disease can be detected early, malignant lymphatic disease is possible, but it is necessary to do a good job of nursing after surgery. At present, the most commonly used methods for malignant lymphomas include surgical resection, radiation (radiotherapy), chemistry (chemotherapy), traditional Chinese medicine, cellular immunity, etc. Surgery combined with chemoradiotherapy has a higher rate or remission rate for malignant lymphoma, while cellular immunity has a synergistic effect on enhancing and restoring the body's immune function, mobilizing the ability to resist disease, and alleviating the body's adverse reactions caused by chemoradiotherapy.

For malignant lymphomas, cellular immunity can be used as an adjunct. Through the introduction of the above content, I believe you have learned what malignant lymphoma can be. Remind everyone to take precautions in life to avoid the occurrence of diseases.

Lymphoma, also known as malignant lymphoma, lymphoma is not benign, once it is found, it is malignant lymphoma, which is a disease of the lymphatic blood system. The clinical manifestations of malignant lymphoma are diverse, including chronic manifestations, progressive manifestations and other manifestations, the main manifestations are ** lymphadenopathy, ** lymphadenopathy is divided into superficial lymphadenopathy and deep lymphadenopathy, and the classification of lymphoma is also rich, mainly divided into Hodgkin lymphoma and non-Hodgkin lymphoma. There are typical Hodgkin lymphomas, lymphocytopenic Hodgkin lymphomas, lymphocyte-predominant Hodgkin lymphomas, and mixed Hodgkin lymphomas.

Non-Hodgkin lymphoma is divided into nearly 100 species in histopathology, mainly divided into T-cell lymphoma and B-cell lymphoma, T-cell lymphoma and B-cell lymphoma, and is divided into high-grade, moderately malignant and low-grade malignancy according to the degree of malignancy.

A pathological diagnosis is first required. Chemotherapy is then given accordingly. It varies depending on the staging**:

Stage I and II patients, such as Hodgkin lymphoma stage I and stage II, can be treated with radiotherapy; Stage III patients can be admitted to chemotherapy, and non-Hodgkin lymphoma can also be treated with chemotherapy combined with radiotherapy; Stem cell transplantation, such as non-Hodgkin lymphoma, mantle cell lymphoma, and T-cell lymphoma, advocates autologous hematopoietic stem cell transplantation.

Controlling infection and reducing exposure to carcinogens can prevent the development of lymphoma.

The development of lymphoma may be related to infection. For example, Helicobacter pylori infection may be associated with the development of lymphoma associated with the gastric mucosa. So we can reduce the occurrence of this part of the lymphoma by ** Helicobacter pylori.

In addition, long-term exposure to radiation, chemotherapy drugs, herbicides, asbestos and other carcinogens may also lead to an increase in the incidence of lymphoma. Therefore, by reducing the exposure to these carcinogens, the occurrence of lymphoma can also be significantly reduced.

Another cause of lymphoma is immunodeficiency. For example, the incidence of lymphoma will also increase in patients with congenital immunodeficiency or immunosuppressants for a long time after liver and kidney transplantation. At this time, we need to have regular re-examinations to detect lymphoma as soon as possible.

The disease has consistency, there is a great difference in the stage, the different stages of lymphoma are different, the intensity and prognosis are very different, the main methods of lymphoma are: mainly according to the patient's condition and stage pathological type to determine, mainly radiotherapy, some types of lymphoma early radiotherapy can be used alone, radiotherapy can also be used to consolidate the effect and adjuvant after chemotherapy in the transplantation process.